What is Innovate Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Innovate's interest expense for the
three
months ended in Mar. 2025 was $ -20 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was $-78 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Innovate's Operating Income for the
three
months ended in Mar. 2025 was $ 3 Mil. Innovate's Interest Expense for the
three
months ended in Mar. 2025 was $ -20 Mil.
Innovate's Interest Coverage for the quarter that ended in Mar. 2025 was 0.17.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Innovate Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innovate (NYSE:VATE) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Innovate's Interest Expense for the
three
months ended in Mar. 2025 was $-20 Mil. Its
Operating Income
for the
three
months ended in Mar. 2025 was $3 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Mar. 2025 was $182 Mil.
Innovate's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Warning Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Innovate Corps earnings cannot cover its interest expense. If the situation continues, the company may have to issue more debt.
Innovate Business Description
Traded in Other Exchanges
Address
295 Madison Avenue, 12th Floor, New York, NY, USA, 10017
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
Executives
| Paul Voigt |
officer: Sr. Managing Dir, Investments |
460 HERNDON PARKWAY, SUITE 150, HERNDON VA 20170 |
| Michael J. Sena |
officer: Chief Financial Officer |
450 PARK AVENUE, 30TH FLOOR, NEW YORK NY 10022 |
| Wayne Jr Barr |
director |
ANACOMP INC, 15378 AVENUE OF SCIENCE, SAN DIEGO CA 92128 |
| Brian Steven Goldstein |
director |
295 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017 |
| Amy Marie Wilkinson |
director |
295 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017 |
| Shelly Lombard |
director |
44 MORSE AVENUE, BLOOMFIELD NJ 07003 |
| Avram A Glazer |
director |
C/O WOODS OVIATT GILMAN LLP, 700 CROSSROADS BUILDING, ROCHESTER NY 14614 |
| Suzi R Herbst |
officer: Chief Administrative Officer |
C/O HC2 HOLDINGS, INC., 450 PARK AVENUE, 30TH FLOOR, NEW YORK NY 10022 |
| Joseph Anthony Ferraro |
officer: Chief Legal Officer & Corp Sec |
56 EMILY ROAD, FAR HILLS FL 07931 |
| Michael Gorzynski |
director, 10 percent owner |
595 MADISON AVE, FLOOR 29, NEW YORK NY 10022 |
| Continental Ltc, Inc. |
10 percent owner |
11001 LAKELINE BLVD., STE. 120, AUSTIN TX 78717 |
| Rio Royal Llc |
10 percent owner |
595 MADISON AVENUE, 29TH FLOOR, NEW YORK NY 10022 |
| Mg Capital Management Ltd. |
10 percent owner |
C/O CAMPBELLS LLP, FLOOR 4, WILLOW HOUSE, CRICKET SQUARE, GRAND CAYMAN E9 KY1-9010 |
| Continental General Insurance Co |
10 percent owner |
11001 LAKELINE BLVD., STE. 120, AUSTIN TX 78717 |
| Continental Insurance Group, Ltd. |
10 percent owner |
11001 LAKELINE BLVD., STE. 120, AUSTIN TX 78717 |
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VATE has been successfully added to your 